secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEAYA Biosciences, Inc. (IDYA)
CIK:        0001676725
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001193125-25-071309
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Susan Kelley to step down from IDEAYA board, move to advisory role
---------------------------------------------------------------------------

- Susan L. Kelley, M.D. will not stand for re-election at the 2025 annual meeting of stockholders.
- She will resign from the Board immediately after the Annual Meeting.
- Kelley intends to transition to Chair of the new Clinical Advisory Board expected before the meeting.
- Board size will decrease to seven directors effective after the Annual Meeting.
- Departure is not due to any disagreement with the Company's operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676725/000119312525071309/0001193125-25-071309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676725/000119312525071309/d906746d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-071309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer